Mibenratide
- Generic Name
- Mibenratide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C87H129N27O30S2
- CAS Number
- 1239011-83-6
- Unique Ingredient Identifier
- P1T1143877
- Background
Mibenratide is under investigation in clinical trial NCT01798745 (A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies).
- Associated Conditions
- -
- Associated Therapies
- -
A Crossover Study to Evaluate the Effect of JNJ-54452840 on Pharmacodynamics of Metoprolol Tartrate Immediate-Release in Healthy Participants
Phase 1
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2013-07-18
- Last Posted Date
- 2016-11-01
- Lead Sponsor
- Janssen Research & Development, LLC
- Registration Number
- NCT01902550
To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian Participants
- First Posted Date
- 2013-03-12
- Last Posted Date
- 2015-03-23
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 32
- Registration Number
- NCT01809353
A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies
- First Posted Date
- 2013-02-26
- Last Posted Date
- 2014-04-09
- Lead Sponsor
- Janssen Research & Development, LLC
- Registration Number
- NCT01798745
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath